Cover Image
市場調查報告書

經皮藥物貼片:產品·適應症·市場與預測

Transdermal Drug Patches to 2022

出版商 Greystone Research Associates 商品編碼 264157
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
經皮藥物貼片:產品·適應症·市場與預測 Transdermal Drug Patches to 2022
出版日期: 2015年06月11日 內容資訊: 英文
簡介

本報告提供經皮藥物貼片市場相關調查分析,提供目前市場·產品及現有·未來預測的產品的市場潛在性分析,貼片設計分析,技術·貼片開發的課題,貼片廠商及第三方供應鏈簡介,40個以上貼片產品詳細內容評估,市場資料及預測,貼片產品供應商與其產品開發活動簡介,經濟,技術及法規要素的影響分析等彙整,為您概述為以下內容。

摘要整理

市場機會

  • 經皮給藥的動態
  • 需求促進因素
  • 競爭情形
  • 阻礙成長要素
  • 藥物動態學及劑形式
  • 貼片製造的動態
  • 貼片製造企業簡介

產品分析:透過經皮貼片的FDA認證的給藥

  • 生物鹼
  • 雄激素
  • 抗憂鬱症藥
  • 制吐藥
  • 鎮護者痙(抗痙攣)藥
  • 中樞神經系統(CNS)刺激藥
  • 膽鹼酯?抑制劑
  • 多巴胺受體激動劑
  • 荷爾蒙補充
  • 降壓藥
  • 局部麻藥
  • NSAID
  • Opioids(類鴉片物質)止痛藥
  • 孕激素
  • 三硝酸物

市場分析:經皮貼片治療

  • ADHD
  • 中毒
  • 避孕
  • 心血管/心絞痛
  • 憂鬱症
  • 荷爾蒙補充療法
  • 高血壓
  • 暈車
  • 神經學
  • 骨質疏鬆症
  • 疼痛管理

市場預測

  • 法規問題
  • IP(智慧財產權)及失效專利
  • 從Rx(處方藥)向OTC(市售藥)的轉換
  • 患者配合度及可用性
  • 醫療經濟

企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: TDP999K

Transdermal drug patches to 2022 analyzes products, markets and commercialization factors for drug patches. The report examines the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more aesthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2022.

What You Will Learn

  • What are the current transdermal drug patch markets and products, and what is the market potential for existing and probable future products?
  • What is the impact of patch designs, technologies and patch development issues on commercialization?
  • Who are the leading patch manufacturers and third-party transdermal supply chain companies?
  • What is the current product and competitive landscape, and what are the details of the numerous products across the various patch product categories and markets?
  • What is the size of the market now, and how will it change in the next seven years to 2022?
  • Who are the transdermal drug patch product providers, and what are their product development activity, and strategies?
  • What is the market impact of economic, technology, and regulatory factors?

Table of Contents

Executive Summary

The Market Opportunity

  • Transdermal Drug Delivery Dynamics
  • Demand Drivers
  • Competitive Landscape
  • Factors Limiting Growth
  • Pharmacokinetics & Dosage Forms
  • Patch Manufacturing Dynamics
  • Patch Manufacturing Company Profiles
  • Product Analysis - FDA-Approved Drugs Delivered via Transdermal Patches

Alkaloids

  • Androgens
  • Antidepressants
  • Antiemetics
  • Antispasmodics
  • CNS Stimulants
  • Cholinesterase Inhibitors
  • Dopamine Agonists
  • Hormone Replacement
  • Hypotensive Agents
  • Local Anesthetics
  • NSAIDs
  • Opioid Analgesics
  • Progestrins
  • Trinitrates

Development-stage Drug Patches

Market Analysis - Transdermal Drug Patch Therapeutics

  • ADHD
  • Addiction
  • Contraception
  • Cardiovascular/Angina
  • Depression
  • Hormone Replacement Therapy
  • Hypertension
  • Motion Sickness
  • Neurology
  • Osteoporosis
  • Pain Management

Market Factors

  • Regulatory Issues
  • IP and Expiring Patents
  • Rx-to-OTC Switching
  • Patient Compliance and Ease of Use
  • Healthcare Economics

Company Profiles

Back to Top